XML 22 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Assets:    
Cash and cash equivalents $ 6,063 $ 4,059
Investments 2,462 2,522
Accounts receivable, net 18,174 17,631
Inventories 15,511 16,450
Other current assets 4,691 4,581
Total current assets 46,901 45,243
Long-term investments 16,973 15,732
Property and equipment, net 11,483 11,349
Operating lease right-of-use assets 20,865 0
Goodwill 79,485 78,678
Intangible assets, net 34,163 36,524
Separate accounts assets 4,271 3,884
Other assets 4,763 5,046
Total assets 218,904 196,456
Liabilities:    
Accounts payable 9,160 8,925
Pharmacy claims and discounts payable 11,937 11,365
Health care costs payable 6,889 6,147
Policyholders’ funds 2,907 2,939
Accrued expenses 10,562 10,711
Other insurance liabilities 1,788 1,937
Current portion of operating lease liabilities 1,793 0
Short-term debt 446 720
Current portion of long-term debt 3,894 1,265
Total current liabilities 49,376 44,009
Long-term operating lease liabilities 18,849 0
Long-term debt 66,941 71,444
Deferred income taxes 7,375 7,677
Separate accounts liabilities 4,271 3,884
Other long-term insurance liabilities 7,965 8,119
Other long-term liabilities 2,528 2,780
Total liabilities 157,305 137,913
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,724 shares issued and 1,299 shares outstanding at June 30, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus 45,719 45,440
Treasury stock, at cost: 425 shares at June 30, 2019 and December 31, 2018 (28,257) (28,228)
Retained earnings 43,136 40,911
Accumulated other comprehensive income 684 102
Total CVS Health shareholders’ equity 61,282 58,225
Noncontrolling interests 317 318
Total shareholders’ equity 61,599 58,543
Total liabilities and shareholders’ equity $ 218,904 $ 196,456